D
MeiraGTx Holdings plc MGTX
$8.12 $0.374.77% NASDAQ
Recommendation
Prev Close
$7.75
Volume
769,987
Avg Vol (90D)
470,819
Market Cap
$623.80M
Dividend & Yield
--
52-Week Range
$4.55 - $9.73
P/E (TTM)
--
EPS (TTM)
-$2.11
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
MeiraGTx Holdings plc (MGTX, $7.84) entered Downtrend as Momentum indicator drops below 0 level on Dec 01, 2025
12/2/2025 - Tickeron - Stocks
MeiraGTx Holdings (MGTX, $8.3) Stochastic Oscillator left the oversold zone on November 28, 2025
11/29/2025 - Tickeron - Stocks
MeiraGTx Holdings plc (MGTX, $8.3) entered Uptrend as Momentum indicator ascends above 0 level on Nov 28, 2025
11/29/2025 - Tickeron - Stocks
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Here's Why
11/27/2025 - MarketBeat
MeiraGTx Holdings (MGTX, $7.46) RSI Indicator left the oversold zone on November 21, 2025
11/22/2025 - Tickeron - Stocks
MeiraGTx Holdings (MGTX, $7.43) RSI Indicator left the oversold zone on November 20, 2025
11/21/2025 - Tickeron - Stocks
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
11/20/2025 - PR Newswire
Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results
11/17/2025 - Simply Wall St
MeiraGTx (NASDAQ:MGTX) Downgraded by Wall Street Zen to "Sell"
11/16/2025 - MarketBeat
MeiraGTx (NASDAQ:MGTX) Announces Quarterly Earnings Results
11/14/2025 - MarketBeat
RBC Capital Keeps Their Buy Rating on Meiragtx Holdings (MGTX)
11/14/2025 - TipRanks Financial Blog
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates
11/13/2025 - Nasdaq News: Stocks
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates
11/13/2025 - Zacks Investment Research
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
11/13/2025 - Globe Newswire
MeiraGTx (NASDAQ:MGTX) Trading 6.6% Higher After Analyst Upgrade
11/12/2025 - MarketBeat
MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of "Moderate Buy" by Analysts
11/12/2025 - MarketBeat
Piper Sandler Increases MeiraGTx (NASDAQ:MGTX) Price Target to $30.00
11/12/2025 - MarketBeat
Chardan Capital Reaffirms Buy Rating for MeiraGTx (NASDAQ:MGTX)
11/12/2025 - MarketBeat
MeiraGTx Holdings (MGTX, $8.9) Stochastic Oscillator left the oversold zone on November 11, 2025
11/12/2025 - Tickeron - Stocks
The volume for MeiraGTx Holdings stock increased for one day, resulting in a record-breaking daily growth of 311% of the 65-Day Volume Moving Average
11/11/2025 - Tickeron - Stocks
MeiraGTx (NASDAQ:MGTX) Sets New 12-Month High - Still a Buy?
11/11/2025 - MarketBeat
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
11/10/2025 - Zacks Investment Research
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
11/10/2025 - Globe Newswire
Alector (ALEC) Reports Q3 Loss, Beats Revenue Estimates
11/6/2025 - Zacks Investment Research
MeiraGTx Holdings (MGTX, $8.58) Stochastic Oscillator left the oversold zone on November 05, 2025
11/6/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$27.42M
EBITDA (TTM)
-$151.43M
EBIT (TTM)
-$163.93M
Net Income (TTM)
-$168.69M
Balance Sheet
Total Assets (Q)
$189.47M
Total Debt (Q)
$88.06M
Total Liabilities (Q)
$230.03M
Book Value Per Share (Q)
-$0.5039
Cash Flow
Cash from Operations (TTM)
-$116.27M
Cash from Investing (TTM)
-$4.24M
Cash from Financing (TTM)
$11.19M
Net Change in Cash (TTM)
-$107.92M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
1.20
7-Day Total Return
8.85%
30-Day Total Return
-12.31%
60-Day Total Return
6.14%
90-Day Total Return
-1.34%
Year to Date Total Return
29.51%
1-Year Total Return
29.92%
2-Year Total Return
55.56%
3-Year Total Return
25.21%
5-Year Total Return
-41.92%
52-week Low
May 14, 2025 - $4.55
52-week High
Nov 10, 2025 - $9.73
Valuation
Market Cap
$623.80M - Small Cap
Enterprise Value
$697.02M
Price/Sales (TTM)
22.88
Price/Book (Q)
-15.38
Dividends and Shares
Shares Outstanding
80.95
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
meiragtx.com
Phone Number
646 860 7985
Address
655 Third Avenue
New York, NY 10017
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed